HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- diethoxyphosphoryl- 2,5,5- trimethylpyrrolidinoxyl

structure in first source

Also Known As:

TMPPO cpd

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Heterocyclic Oxides
  - Cyclic N-Oxides: 3
    - 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl: 1

Experts

1.	Caffaratti, Sophie: 1 article (05/2003)
2.	Culcasi, Marcel: 1 article (05/2003)
3.	Mathieu, Corinne: 1 article (05/2003)
4.	Mercier, Anne: 1 article (05/2003)
5.	Pietri, Sylvia: 1 article (05/2003)

Related Diseases

1.	Reperfusion Injury 05/01/2003 - "Using hemodynamic, metabolic, and enzymatic indices of reperfusion injury, the efficacy of 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl (TMPPO), a five-membered ring beta-phosphorylated nitroxide, has been compared to that of TEMPO when added at a nontoxic concentration (1 mM) in buffer-perfused isolated rat hearts during low-flow ischemia, total ischemia, and reflow. "
2.	Ischemia 05/01/2003 - "Using hemodynamic, metabolic, and enzymatic indices of reperfusion injury, the efficacy of 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl (TMPPO), a five-membered ring beta-phosphorylated nitroxide, has been compared to that of TEMPO when added at a nontoxic concentration (1 mM) in buffer-perfused isolated rat hearts during low-flow ischemia, total ischemia, and reflow. "
3.	Myocardial Ischemia (Ischemic Heart Diseases) 05/01/2003 - "Hemodynamic and metabolic effects of the beta-phosphorylated nitroxide 2-diethoxyphosphoryl-2,5,5-trimethylpyrrolidinoxyl during myocardial ischemia and reperfusion."

Related Drugs and Biologics

1.	Buffers
2.	nitroxyl
3.	TEMPO